Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00752_DB00921_nanopub.RAKjFPY2AY3DvMCw2W9bBVwwN40bo4-GGDQopBu2BLOnk#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00752_DB00921 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00752_DB00921 label "DDI between Tranylcypromine and Buprenorphine - Buprenorphine may enhance the adverse/toxic effect of MAO Inhibitors like tranylcypromine. When possible, avoid use of buprenorphine in patients who have used a monoamine oxidase inhibitor within the past 14 days due to possible severe adverse effects. [drugbank_resource:DB00752_DB00921]" assertion.
- drugbank_resource:DB00752_DB00921 identifier "drugbank_resource:DB00752_DB00921" assertion.
- drugbank_resource:DB00752_DB00921 title "DDI between Tranylcypromine and Buprenorphine - Buprenorphine may enhance the adverse/toxic effect of MAO Inhibitors like tranylcypromine. When possible, avoid use of buprenorphine in patients who have used a monoamine oxidase inhibitor within the past 14 days due to possible severe adverse effects." assertion.
- drugbank:DB00752 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00752_DB00921 assertion.
- drugbank:DB00921 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00752_DB00921 assertion.